Kyung B. Ha
Hwasun, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Synergistic effects of C-C chemokine receptor 2 inhibitor and transforming growth factor-β type I receptor kinase inhibitor combination in metabolic dysfunction-associated steatohepatitis.
Journal: Metabolism: clinical and experimental
Published: April 04, 2025
DA-6034 ameliorates hepatic steatosis and inflammation in high fat diet-induced obese mice.
Journal: Journal of Yeungnam medical science
Published: December 14, 2023
DWN12088, A Prolyl-tRNA Synthetase Inhibitor, Alleviates Hepatic Injury in Nonalcoholic Steatohepatitis.
Journal: Diabetes & metabolism journal
Published: October 20, 2022
Umbelliferone Ameliorates Hepatic Steatosis and Lipid-Induced ER Stress in High-Fat Diet-Induced Obese Mice.
Journal: Yonsei medical journal
Published: August 17, 2022
Beneficial Effects of a Curcumin Derivative and Transforming Growth Factor-β Receptor I Inhibitor Combination on Nonalcoholic Steatohepatitis.
Journal: Diabetes & metabolism journal
Published: April 01, 2022
EW-7197 Attenuates the Progression of Diabetic Nephropathy in db/db Mice through Suppression of Fibrogenesis and Inflammation.
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: October 12, 2021
Intestinal interleukin-22 enhances GLP-1 production via the STAT3 pathway to improve glucose homeostasis during high-fat diet induced obesity in a study with male mice.
Journal: Nature communications
Published: May 26, 2021
Tetrahydrocurcumin Ameliorates Kidney Injury and High Systolic Blood Pressure in High-Fat Diet-Induced Type 2 Diabetic Mice.
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: February 08, 2021
APX-115, a pan-NADPH oxidase inhibitor, protects development of diabetic nephropathy in podocyte specific NOX5 transgenic mice.
Journal: Free radical biology & medicine
Published: June 02, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026